Last reviewed · How we verify
ESPB
At a glance
| Generic name | ESPB |
|---|---|
| Also known as | 0,2% ropivacaine |
| Sponsor | Kasr El Aini Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Erector Spinae Block Vs Ketamine-based Multimodal Analgesia Protocol in Lumber Decompressive Surgery (NA)
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- Analgesic Techniques for Robotic Prostatectomy Procedures (NA)
- Ultrasound-Guided SPSIP Versus ESPB for Postoperative Pain After Modified Radical Mastectomy (NA)
- Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block (NA)
- Erector Spinae Plane Block for Acute Low Back Pain (NA)
- Effects of Erector Spinae Plane Block on Postoperative Pain Following Lumbar Fusion Surgery (NA)
- External Oblique Intercostal Block Versus Erector Spinae Plane Block on Postoperative Pain in Laparoscopic Radical Gastrectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ESPB CI brief — competitive landscape report
- ESPB updates RSS · CI watch RSS
- Kasr El Aini Hospital portfolio CI